Acumen Pharmaceuticals, Inc. (ABOS): Price and Financial Metrics
ABOS Price/Volume Stats
Current price | $1.07 | 52-week high | $3.92 |
Prev. close | $1.01 | 52-week low | $0.86 |
Day low | $1.00 | Volume | 165,300 |
Day high | $1.09 | Avg. volume | 245,370 |
50-day MA | $1.10 | Dividend yield | N/A |
200-day MA | $1.94 | Market Cap | 64.81M |
ABOS Stock Price Chart Interactive Chart >
Acumen Pharmaceuticals, Inc. (ABOS) Company Bio
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
ABOS Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | -55.23% |
1-year | -70.68% |
3-year | -69.16% |
5-year | N/A |
YTD | -37.79% |
2024 | -55.21% |
2023 | -28.89% |
2022 | -20.12% |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...